Fresenius Medical Care Analyst Ratings
Fresenius Medical Care Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/23/2023 | 9.97% | Truist Securities | $17 → $22 | Maintains | Hold |
| 06/22/2022 | 34.97% | Truist Securities | $34 → $27 | Maintains | Hold |
| 11/23/2021 | — | HSBC | Initiates Coverage On | → Hold | |
| 11/17/2021 | 74.96% | RBC Capital | $42 → $35 | Maintains | Sector Perform |
| 11/11/2021 | — | Jefferies | Upgrades | Underperform → Hold | |
| 05/21/2020 | 139.94% | SunTrust Robinson Humphrey | $46 → $48 | Maintains | Buy |
| 05/11/2020 | 129.94% | SunTrust Robinson Humphrey | $42 → $46 | Maintains | Buy |
| 04/13/2020 | 109.95% | SunTrust Robinson Humphrey | $46 → $42 | Maintains | Buy |
| 02/21/2020 | 129.94% | CFRA | $38 → $46 | Upgrades | Hold → Buy |
| 01/21/2020 | — | Jefferies | Upgrades | Hold → Buy | |
| 10/23/2019 | — | Redburn Partners | Downgrades | Buy → Neutral | |
| 08/01/2019 | — | BTIG | Downgrades | Buy → Neutral | |
| 06/20/2019 | — | Barclays | Upgrades | Equal-Weight → Overweight | |
| 10/26/2018 | — | UBS | Upgrades | Neutral → Buy | |
| 10/18/2018 | — | DZ Bank | Downgrades | Buy → Hold | |
| 08/28/2018 | — | HSBC | Upgrades | Hold → Buy | |
| 04/24/2018 | — | Deutsche Bank | Upgrades | Hold → Buy |
| 日期 | 上/下行 | 分析師公司 | 价格目標變更 | 評級變更 | 上一頁/目前評分 |
|---|---|---|---|---|---|
| 02/23/2023 | 9.97% | 真理證券 | 十七美元 → 22 美元 | 維護 | 保持 |
| 2022 年 06 月 22 日 | 34.97% | 真理證券 | 三十四美元 → 二十七美元 | 維護 | 保持 |
| 11/23/2021 | — | 匯豐 | 啟動覆蓋範圍 | → 保持 | |
| 11/17/2021 | 74.96% | 加拿大紅銀資本 | 四十二美元 → 35 美元 | 維護 | 部門執行 |
| 11/11/2021 | — | 富瑞集團 | 升級 | 表現不足 → 保持 | |
| 2020 年 5 月 21 日 | 139.94% | 太陽信託羅賓遜·漢弗萊 | 四十六美元 → 四十八美元 | 維護 | 購買 |
| 05/11/2020 | 129.94% | 太陽信託羅賓遜·漢弗萊 | 四二美元 → 四十六美元 | 維護 | 購買 |
| 2020 年 4 月 13 日 | 109.95% | 太陽信託羅賓遜·漢弗萊 | 四六美元 → 四十二美元 | 維護 | 購買 |
| 02/21/2020 | 129.94% | CFRA | 三八美元 → 四十六美元 | 升級 | 持有 → 購買 |
| 01/21/2020 | — | 富瑞集團 | 升級 | 持有 → 購買 | |
| 10/23/2019 | — | 雷德本合作夥伴 | 降級 | 購買 → 中性 | |
| 08/01/2019 | — | BTIG | 降級 | 購買 → 中性 | |
| 06/20/2019 | — | 巴克萊 | 升級 | 同等體重 → 超重 | |
| 10/26/2018 | — | 瑞銀（UBS） | 升級 | 中性 → 購買 | |
| 10/18/2018 | — | DZ 銀行 | 降級 | 購買 → 持有 | |
| 2018 年 8 月 28 日 | — | 匯豐 | 升級 | 持有 → 購買 | |
| 2018 年 4 月 24 日 | — | 德意志银行 | 升級 | 持有 → 購買 |
What is the target price for Fresenius Medical Care (FMS)?
費森尤斯醫療保健（FMS）的目標價格是多少？
The latest price target for Fresenius Medical Care (NYSE: FMS) was reported by Truist Securities on February 23, 2023. The analyst firm set a price target for $22.00 expecting FMS to rise to within 12 months (a possible 9.97% upside). 2 analyst firms have reported ratings in the last year.
真理證券於 2023 年 2 月 23 日報導了費森尤斯醫療保健（紐約證券交易所代碼：FMS）的最新價格目標。該分析師公司設定了 22.00 美元的價格目標，預計 FMS 將在 12 個月內上升（可能是 9.97％ 的上漲幅度）。2 家分析師公司在去年報告了評級。
What is the most recent analyst rating for Fresenius Medical Care (FMS)?
費森尤斯醫療 (FMS) 的最新分析師評級為何？
The latest analyst rating for Fresenius Medical Care (NYSE: FMS) was provided by Truist Securities, and Fresenius Medical Care maintained their hold rating.
菲森尤斯醫療保健（紐約證券交易所：FMS）的最新分析師評級由真理證券提供，弗雷森尤斯醫療保持其保持等級。
When is the next analyst rating going to be posted or updated for Fresenius Medical Care (FMS)?
弗雷森尤斯醫療保健（FMS）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Fresenius Medical Care, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Fresenius Medical Care was filed on February 23, 2023 so you should expect the next rating to be made available sometime around February 23, 2024.
分析師進行了廣泛的研究，其中包括通過公共財務報表，與 Fresenius 醫療保健的高管和客戶交談，以及聽取盈利電話會議後，分析師到達股票評級。大多數分析師每三個月這樣做一次，因此您應該每年每家公司獲得 4 個評級。弗雷森尤斯醫療保健的最後評級於 2023 年 2 月 23 日提交，因此您應該期望下一個評分將在 2024 年 2 月 23 日左右的某個時間提供。
Is the Analyst Rating Fresenius Medical Care (FMS) correct?
分析師評級費森尤斯醫療保健（FMS）是否正確？
While ratings are subjective and will change, the latest Fresenius Medical Care (FMS) rating was a maintained with a price target of $17.00 to $22.00. The current price Fresenius Medical Care (FMS) is trading at is $20.01, which is within the analyst's predicted range.
儘管評級是主觀的並且會發生變化，但最新的費森尤斯醫療（FMS）評級維持，目標價格為 17.00 美元至 22.00 美元。費森尤斯醫療保健（FMS）的當前價格為 20.01 美元，該價格在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。